In the News

FDA’s Shift From Animal Testing Opens Doors for Organoid Makers

April 30, 2025
Loading the Elevenlabs Text to Speech AudioNative Player...

-

28bio Launches CNS-3D Plasticity Organoids to Assess Drug Effects on Human Learning and Memory
CNS-3D Plasticity Organoids enable human functional endpoints of learning and memory.
28bio Launches CNS-3D Alzheimer’s Model to Predict Therapeutic Efficacy
The CNS-3D Induced Alzheimer’s Model is a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients.
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy